VBP (voluem-based procurement)

China’s Seventh National VBP Round for Medical Consumables Concludes in Tianjin – 517 Digestive Intervention Products Selected Across 23 Categories

The seventh batch of China’s state‑organized centralized volume‑based procurement (VBP) of medical consumables opened bids...

Policy / Regulatory

China’s 12th National Drug Volume-Based Procurement Yields Preliminary Winners with Originator Drugs Securing Key Positions

Fineline Cube Aug 3, 2026

China’s National Joint Procurement Office (NJPO) announced preliminary results for the 12th batch of national...

Policy / Regulatory

China’s 12th National Drug Procurement Round Attracts 500+ Companies, Targets 7.34 Billion Units

Fineline Cube Jul 29, 2026

China’s National Drug Joint Procurement Office released enterprise-related information for the 12th batch of national...

Policy / Regulatory

China Announces 12th National Drug Volume-Based Procurement with Enhanced Pricing Mechanism and Expanded Participation

Fineline Cube Jul 23, 2026

The National Joint Procurement Office announced on July 22, 2026 that the 12th batch of...

Policy / Regulatory

China Launches 12th Batch of National Drug Procurement with Vonoprazan and Vitamin B6 Drawing Record Competition

Fineline Cube Jul 21, 2026

The National Joint Procurement Office (NJPO) has issued the Notice on Corporate Affiliations for the...

Policy / Regulatory

China Launches 12th National Drug Volume-Based Procurement Batch with 65 Products, Patent Disputes Highlighted

Fineline Cube Jun 24, 2026

The National Organized Drug Joint Procurement Office announced the 12th batch of national organized drug...

Policy / Regulatory

Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement

Fineline Cube Jun 23, 2026

The Anhui Provincial Healthcare Security Administration has formally invited other provinces to participate in a...

Company Drug Policy / Regulatory

PKU Hi-Tech Huatai Pharmaceuticals Blacklisted from China’s Volume-Based Procurement Following Quality Compliance Failures

Fineline Cube Jun 11, 2026

PKU Hi-Tech Huatai Pharmaceuticals Co., Ltd. has been blacklisted from China’s national volume-based procurement (VBP)...

Policy / Regulatory

China’s National Drug Alliance Procurement Office Suspends Harbin Liqiang’s Loxoprofen Gel Patch Production and Imposes 18-Month VBP Ban

Fineline Cube May 8, 2026

The National Drug Alliance Procurement Office, administrator of China’s volume-based procurement (VBP) program, announced the...

Policy / Regulatory

China Imposes Historic Four-Year VBP Ban on Fu Kang Ren, Hetero Labs for Supply Failures; Hehe and Tiantaishan Also Penalized

Fineline Cube Apr 7, 2026

The National Drug Alliance Procurement Office has revoked the Volume-Based Procurement (VBP) winning bid qualifications...

Policy / Regulatory

NHSA Launches 6th VBP Tender for Medical Consumables in China, Targeting Drug-Coated Balloons

Fineline Cube Jan 13, 2026

China’s National Healthcare Security Administration (NHSA) conducted the 6th volume-based procurement (VBP) tender for high-value...

Policy / Regulatory

SSY Group Limited Projected to Win 12 Products in China’s Eleventh VBP Round

Fineline Cube Oct 28, 2025

China‑based SSY Group Limited (HKG: 2005) announced today that it has been pre‑selected as the...

Policy / Regulatory

VBP 11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement

Fineline Cube Oct 23, 2025

The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for...

Policy / Regulatory

Zhejiang Authority Imposes Administrative Penalties on Dahongying Pharma for Substandard Fluorouracil Injection

Fineline Cube Oct 16, 2025

The Zhejiang Provincial Medical Products Administration announced that Ningbo Dahongying Pharmaceutical Co., Ltd. has been...

Policy / Regulatory

National Joint Procurement Office Announces 11th Round VBP, AstraZeneca Dapagliflozin Leads Demand

Fineline Cube Oct 15, 2025

On October 11, 2025, the National Joint Procurement Office (NJPO) released the full company list for...

Company Drug Policy / Regulatory

National Drug Alliance Moves VBP 11th‑Round Information Disclosure Conference to 27 Oct 2025 in Shanghai

Fineline Cube Oct 11, 2025

The National Drug Alliance Procurement Office announced a schedule change for the 11th round of...

Policy / Regulatory

China Drug Procurement: Centralized Rules Shape 11th Round Of VBP

Fineline Cube Sep 23, 2025

The Joint Procurement Office of the National Healthcare Security Administration (NHSA) published the definitive rules...

Company Drug Policy / Regulatory

NHSA Updates Volume-Based Procurement Policy for Medical Institutions in 11th VBP Tender

Fineline Cube Aug 7, 2025

The National Healthcare Security Administration (NHSA) has released Q&As on the medical institutions’ volumes filing...

Policy / Regulatory

NHSA Announces Reforms to Centralized Drug Procurement Policies Beyond Lowest Price

Fineline Cube Jul 24, 2025

The National Healthcare Security Administration (NHSA) held a press conference today on the “High-Quality Completion...

Policy / Regulatory

NHSA Strengthens Pharmaceutical Pricing and Procurement Credit Evaluation Mechanism

Fineline Cube Jun 6, 2025

The National Healthcare Security Administration (NHSA) issued a notification this week to refine its credit...

VBP (voluem-based procurement)

China’s Seventh National VBP Round for Medical Consumables Concludes in Tianjin – 517 Digestive Intervention Products Selected Across 23 Categories

China’s 12th National Drug Volume-Based Procurement Yields Preliminary Winners with Originator Drugs Securing Key Positions

China’s 12th National Drug Procurement Round Attracts 500+ Companies, Targets 7.34 Billion Units

China Announces 12th National Drug Volume-Based Procurement with Enhanced Pricing Mechanism and Expanded Participation

China Launches 12th Batch of National Drug Procurement with Vonoprazan and Vitamin B6 Drawing Record Competition

China Launches 12th National Drug Volume-Based Procurement Batch with 65 Products, Patent Disputes Highlighted

Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement

PKU Hi-Tech Huatai Pharmaceuticals Blacklisted from China’s Volume-Based Procurement Following Quality Compliance Failures

China’s National Drug Alliance Procurement Office Suspends Harbin Liqiang’s Loxoprofen Gel Patch Production and Imposes 18-Month VBP Ban

China Imposes Historic Four-Year VBP Ban on Fu Kang Ren, Hetero Labs for Supply Failures; Hehe and Tiantaishan Also Penalized

NHSA Launches 6th VBP Tender for Medical Consumables in China, Targeting Drug-Coated Balloons

SSY Group Limited Projected to Win 12 Products in China’s Eleventh VBP Round

VBP 11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement

Zhejiang Authority Imposes Administrative Penalties on Dahongying Pharma for Substandard Fluorouracil Injection

National Joint Procurement Office Announces 11th Round VBP, AstraZeneca Dapagliflozin Leads Demand

National Drug Alliance Moves VBP 11th‑Round Information Disclosure Conference to 27 Oct 2025 in Shanghai

China Drug Procurement: Centralized Rules Shape 11th Round Of VBP

NHSA Updates Volume-Based Procurement Policy for Medical Institutions in 11th VBP Tender

NHSA Announces Reforms to Centralized Drug Procurement Policies Beyond Lowest Price

NHSA Strengthens Pharmaceutical Pricing and Procurement Credit Evaluation Mechanism

You Missed

Hainan Boao Lecheng Pilot Zone Issues Exit Mechanism Rules for Clinical Translation of New Biomedical Technologies – Full‑Process Framework for Suspension, Exit and Resumption

BRL Medicine’s Allogeneic CD19 CAR‑T Included in CDE’s “Care Program‑Extension” – Rare Disease Fast Track for Relapsed/Refractory Systemic Sclerosis

Walvax’s Third‑Generation COVID‑19 mRNA Vaccine Wins NMPA Approval – JN.1‑Based Shot Clears Regulatory Bar for Adults in China

China’s Seventh National VBP Round for Medical Consumables Concludes in Tianjin – 517 Digestive Intervention Products Selected Across 23 Categories